Metastic Thyroid Cancer study: 68-Gallium-DOTATATE-PET/CT
Official title The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
ClinicalTrials.gov ID: NCT04927416
What this study is testing
What is 68-Gallium-DOTATATE-PET/CT?
An investigational imaging agent being studied to help detect metastatic thyroid cancer.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to find out which patients’ thyroid cancer tumors take up the 68‑Gallium‑DOTATATE tracer, which could help future treatment plans.
- Who it's for
- Adults 18 years or older whose thyroid cancer has spread beyond the thyroid gland.
- What's involved
- Participants will have a medical exam, give blood and urine samples, and undergo several imaging scans (CT, bone scan, MRI, and a PET/CT). They will receive an IV line and an injection of the radioactive tracer, and the PET/CT scan will take about 90 minutes.
- Time commitment
- The study lasts about three months and includes multiple visits for exams and imaging.
- Phase 2: a mid-size study of how well it works
- Time commitment: about 3 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 98
You may be able to join if
- Data prospectively collected from the 28 people enrolled under this protocol, and data from 26 people collected under 77-DK-0096 and/or 00-CH-0093...
- Patients with HTC, DTC, and MTC will be identified by the investigators.
You likely can't join if
- Male or female, aged \>18 years.
- Male or female, aged \>18 years.
- Pregnancy or lactation by self-report.
- Serious underlying medical conditions that restrict diagnostic testing or therapy such as renal failure, congestive cardiac failure or active...
- Patients unable to give informed consent.
The study team makes the final eligibility decision.
Where it is enrolling
- Bethesda, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 3 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 98 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Bethesda, Maryland, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.